These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3684986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Use of rifampicin in venous perfusion in tuberculosis].
    Perna G, Natale F.
    Clin Ter; 1979 Jul 15; 90(1):63-73. PubMed ID: 535329
    [No Abstract] [Full Text] [Related]

  • 4. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A, Ciobanu V, Cojocaru G, Borşaru I, Ciobanu D, Spirescu G, Roşianu D, Pescariu M.
    Ftiziologia; 1971 Jul 15; 20(6):623-8. PubMed ID: 5162289
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
    Ursov IG, Krasnov VA, B1tashova VA, Kudelia OA, Volkova ZhA, Gromyko NI, Borovinskaia TA.
    Probl Tuberk; 1998 Jul 15; (4):21-2. PubMed ID: 9771031
    [Abstract] [Full Text] [Related]

  • 7. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov 15; 46(11):423-8. PubMed ID: 4335256
    [No Abstract] [Full Text] [Related]

  • 8. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS.
    Probl Tuberk Bolezn Legk; 2008 Nov 15; (12):60-3. PubMed ID: 19227326
    [Abstract] [Full Text] [Related]

  • 9. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G.
    Arch Tisiol Mal Appar Respir; 1968 Jun 15; 23(6):461-6. PubMed ID: 5309059
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES, Abrarov BA.
    Probl Tuberk; 1986 Jun 15; (5):27-30. PubMed ID: 3526322
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar 15; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
    Firsova VA, Nadyrshina RSh, Melikova VM.
    Probl Tuberk; 1986 Mar 15; (5):14-7. PubMed ID: 3737587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.